Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer.

Xuning WangShixiang WangYalin HanMaolin XuPeng LiMu KeZhipeng TengPu HuangZiyan DiaoYongfeng YanQingyu MengYanshen KuangWei ZhengHongyi LiuXuesong LiuBaoqing Jia

Published in: International journal of general medicine (2021)

CSMD1 mutation may act as a novel biomarker for assessing the survival and immune therapy response in patients with gastric cancer.

Keyphrases

risk factors
stem cells
free survival
mesenchymal stem cells
bone marrow
smoking cessation